Comprehensive National Inpatient Sample data reveals low but rising Pneumocystis jiroveci pneumonia risk in inflammatory bowel disease patients

BACKGROUND: There are only limited data to guide the management of infectious risk for Pneumocystis jiroveci pneumonia (PCP) in patients with inflammatory bowel disease (IBD). We evaluated the frequency of admissions for PCP among patients with IBD, as well as the temporal trend in PCP admission rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Jeffrey, Stein, Daniel J., Feuerstein, Joseph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062846/
https://www.ncbi.nlm.nih.gov/pubmed/35599933
http://dx.doi.org/10.20524/aog.2022.0713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062846/
https://www.ncbi.nlm.nih.gov/pubmed/35599933
http://dx.doi.org/10.20524/aog.2022.0713

Ejemplares similares